| Product Code: ETC8262573 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of neuraminidase inhibitors to Mauritius in 2024 saw a shift in market concentration levels, transitioning from high concentration in 2023 to moderate concentration. Key exporting countries to Mauritius included India, Metropolitan France, Germany, Turkey, and the UK. The compound annual growth rate (CAGR) for the period 2020-2024 was a healthy 4.71%, indicating steady growth in the market. However, there was a slight decline in growth rate from 2023 to 2024 at -1.38%, suggesting a possible stabilization phase in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Neuraminidase Inhibitors Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, 2022 & 2032F |
3.3 Mauritius Neuraminidase Inhibitors Market - Industry Life Cycle |
3.4 Mauritius Neuraminidase Inhibitors Market - Porter's Five Forces |
3.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.7 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Mauritius Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Mauritius Neuraminidase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Neuraminidase Inhibitors Market Trends |
6 Mauritius Neuraminidase Inhibitors Market, By Types |
6.1 Mauritius Neuraminidase Inhibitors Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2022 - 2032F |
6.1.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2022 - 2032F |
6.1.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Mauritius Neuraminidase Inhibitors Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2022 - 2032F |
6.2.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2022 - 2032F |
6.2.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2022 - 2032F |
6.2.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2022 - 2032F |
6.2.6 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Mauritius Neuraminidase Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2022 - 2032F |
6.3.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2022 - 2032F |
6.3.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 Mauritius Neuraminidase Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2022 - 2032F |
6.4.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
6.5 Mauritius Neuraminidase Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.5.3 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
6.5.4 Mauritius Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
7 Mauritius Neuraminidase Inhibitors Market Import-Export Trade Statistics |
7.1 Mauritius Neuraminidase Inhibitors Market Export to Major Countries |
7.2 Mauritius Neuraminidase Inhibitors Market Imports from Major Countries |
8 Mauritius Neuraminidase Inhibitors Market Key Performance Indicators |
9 Mauritius Neuraminidase Inhibitors Market - Opportunity Assessment |
9.1 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2022 & 2032F |
9.3 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Mauritius Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Mauritius Neuraminidase Inhibitors Market - Competitive Landscape |
10.1 Mauritius Neuraminidase Inhibitors Market Revenue Share, By Companies, 2025 |
10.2 Mauritius Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here